Functional Neurological Disorder Diagnosis: Positive Signs and Medical Assessment
Author: Angela Bogdanova · Published: October 12, 2026 · Editorial Policy
Research cluster: Somatic Symptom & Functional Disorders · Written by Artificial Sapiens
Functional neurological disorder (FND) is diagnosed through a clinical assessment that identifies positive evidence of altered nervous-system functioning while evaluating other conditions that may account for the person's symptoms. A positive FND diagnosis is supported by findings such as characteristic differences between voluntary and automatic movement, tremor that changes with a competing rhythm, or well-characterized seizure-like events investigated with appropriate expertise. A normal MRI, a normal routine EEG, an emotionally stressful period, or the presence of anxiety does not independently establish FND.
The distinction matters because functional weakness, tremor, seizures, sensory changes, speech symptoms, and other neurological complaints are real and can be disabling. A person may have FND alongside epilepsy, multiple sclerosis, migraine, stroke-related impairment, another neurological disease, or a medical condition. Assessment therefore has two complementary purposes: identifying convincing evidence for the functional symptom pattern and identifying any additional condition that needs its own care. This article explains how clinicians make that judgment, the strengths and limitations of commonly used examination signs, the place of MRI, EEG, EMG, and other tests, and the questions patients can ask when receiving a diagnosis. Aybek and Perez, 2022; Finkelstein and Popkirov, 2023.
What does a positive diagnosis of FND mean?
A positive clinical sign is an observed or elicited finding whose pattern supports a particular diagnosis. In FND, the most useful signs demonstrate internal inconsistency within a neurological task or a clinically meaningful pattern of incongruence with the way recognized neurological diseases usually affect movement, sensation, or episodes of altered awareness. Internal inconsistency has a specific clinical meaning: performance differs in a reproducible and diagnostically informative way across conditions, such as voluntary effort and automatic movement. It is not a judgment about the person's honesty or motivation.
A clinician may observe that a leg appears weak during one form of strength testing but produces substantially greater force when the other leg performs a coordinated action. With functional tremor, the frequency or appearance of the movement may change under specific motor tasks. Such findings are interpreted together with the history, other examination results, the symptom subtype, and competing explanations. Their value depends on correct technique, the patient's ability to participate, and the clinical situation. Dolbow et al., 2025; Mavroudis et al., 2025.
The modern rule-in approach provides a basis for communicating what the examiner found. It does not mean that every patient must have every sign, that every sign has identical diagnostic accuracy, or that one positive maneuver eliminates the possibility of another illness. The evidence supporting different signs ranges from small prospective studies to larger observational series and expert syntheses. Diagnostic accuracy estimates often come from specialist settings and may not generalize to emergency departments, children, patients with pain, or people with several neurological disorders. Aybek and Perez, 2022; Practical guide to functional motor weakness, 2025.
How FND is classified: DSM-5-TR and ICD-11
The DSM-5-TR uses the designation functional neurological symptom disorder (conversion disorder) within somatic symptom and related disorders. Its diagnostic framework requires one or more symptoms of altered voluntary motor or sensory function, clinical findings that provide evidence of incompatibility between the symptom and recognized neurological or medical conditions, the absence of a better explanation for that symptom by another disorder, and clinically significant distress, impairment, or a need for medical evaluation. The manual specifies presentations such as weakness or paralysis, abnormal movement, swallowing or speech symptoms, attacks or seizures, anesthesia or sensory loss, and special sensory symptoms. A preceding psychological stressor is not required. American Psychiatric Association, 2022; APA DSM-5-TR terminology update.
ICD-11 places the corresponding category, dissociative neurological symptom disorder, within dissociative disorders, using symptom-based specifications. This is a different organizational and conceptual approach; it should be documented according to the clinician's relevant classification system rather than assumed to be word-for-word identical to DSM-5-TR FND. Neither classification requires a clinician to infer that a patient deliberately produces neurological symptoms. World Health Organization, ICD-11 clinical descriptions, 2024; First et al., 2021.
Functional neurological disorder also differs from somatic symptom disorder. The latter focuses on a particular pattern of distressing physical symptoms accompanied by excessive thoughts, feelings, or behaviors related to them; neurological rule-in signs are central to diagnosing the relevant forms of FND. Both diagnoses may be considered in appropriate clinical circumstances, but the presence of persistent bodily symptoms alone does not establish either.
What happens during a medical assessment for suspected FND?
The medical history establishes the pattern
The clinician asks what happens during the symptom, when it started, how quickly it developed, how long it lasts, and what changes its severity. They explore the person's first and most typical events, frequency, progression, injuries, medication exposures, previous neurological diagnoses, family and personal medical history, and the effects on walking, driving, education, work, communication, sleep, and daily life.
For intermittent episodes, the clinician may request a witness description or an appropriately obtained smartphone video. For motor symptoms, details about task-dependent change, falls, pain, fatigue, and available movements help determine which examination maneuvers are informative. For cognitive complaints, longitudinal change and independent daily functioning matter. For seizure-like episodes, descriptions of awareness, responsiveness, breathing, movements, recovery, and whether different event types occur are important, although no single behavioral feature conclusively separates all functional and epileptic seizures. Aybek and Perez, 2022; AAN functional seizures guideline, 2026.
Questions about stress, adverse experiences, mood, anxiety, dissociation, sleep, and relationships may be clinically useful because these factors can affect overall health and treatment planning. They should be asked respectfully and without making disclosure of trauma a prerequisite for neurological assessment. Trauma is associated with FND in some research, but an association in a population does not establish the cause of an individual's symptoms. Many people with FND have no identified precipitating psychological event. Aybek and Perez, 2022.
The neurological examination tests more than one possibility
A neurologist examines muscle power, tone, reflexes, coordination, sensory function, eye movements, balance, gait, and other systems relevant to the complaint. This examination looks for findings that support an FND presentation and signs pointing toward central nervous system, peripheral nerve, neuromuscular, movement, vestibular, or other diseases. The clinician may deliberately compare spontaneous movement, instructed movement, simultaneous activity, and attention-dependent tasks.
Normal reflexes or preserved movement in one context can be valuable details, but the strength of the conclusion comes from the integrated pattern. Pain, fear of falling, medication effects, cognitive impairment, communication barriers, weakness affecting both sides, and difficulty understanding the maneuver can alter the validity of a test. Examination should be adapted for age, mobility, disability, and safety rather than mechanically repeated until a desired sign appears. Finkelstein and Popkirov, 2023; Practical guide to functional motor weakness, 2025.
The clinician decides which investigations are indicated
Investigations may be necessary to evaluate the onset, severity, localization, red flags, and plausible alternative diagnoses. The goal is to answer an actual clinical question. MRI, CT, blood tests, EEG, video-EEG, electromyography, nerve-conduction studies, and specialized vestibular or cognitive assessments are selected according to the presentation. There is no universal laboratory panel, scan, or brain activity marker that independently proves all FND subtypes.
An examination that convincingly identifies a functional motor pattern may allow the clinician to explain FND before every conceivable disease has been tested. At the same time, urgent symptoms, atypical findings, meaningful progression, new examination abnormalities, and additional medical problems may require targeted investigation or reassessment. Aybek and Perez, 2022; Finkelstein and Popkirov, 2023.
Positive clinical signs of functional limb weakness
Hoover's sign: the relationship between voluntary and automatic hip extension
Hoover's sign evaluates a particular pattern of leg weakness. During a clinician-performed maneuver, force produced by one leg is compared under different conditions involving movement of the opposite leg. A supportive functional pattern occurs when apparently weak voluntary hip extension is accompanied by substantially better automatic extension during contralateral hip flexion. The demonstration shows that a motor pathway can produce force in one context despite reduced access to that movement in another.
The maneuver needs correct positioning, understandable instructions, sufficient strength in the comparison leg, and attention to pain and other confounders. It is particularly relevant to certain unilateral patterns of lower-limb weakness; it cannot be treated as a universal test for every weak limb. Pain-limited effort and neglect may change interpretation. A 2025 review notes that widely repeated pooled accuracy figures rely on a small evidence base; the one prospective study cited included only eight participants with functional leg weakness and reported lower sensitivity than pooled estimates. For that reason, neither a positive nor a negative Hoover's sign should be used as the sole basis for a major diagnosis. Practical guide to functional motor weakness, 2025.
Hip abductor sign
The hip abductor sign likewise investigates relationships between movement on the affected side and a coordinated task on the opposite side. A clinician looks for improvement in apparently weak hip abduction when the contralateral hip abducts against resistance. As with Hoover's sign, the finding is interpreted in the context of the full examination and valid performance conditions. Evidence for its diagnostic accuracy is more limited than confident informal descriptions sometimes imply. Practical guide to functional motor weakness, 2025.
Give-way weakness and variation across tasks
During strength testing, some patients show a sudden reduction of force after initially generating resistance. This is often called give-way or collapsing weakness. It can support a functional formulation when reproducible and combined with other meaningful positive findings. However, pain, fatigue, fear, poor understanding, and other circumstances may also produce interrupted resistance. The examiner must consider those circumstances before assigning diagnostic significance.
Differences between formal strength testing and observed automatic movement may be informative, particularly when they occur in a characteristic pattern and alongside other positive findings. Such variation should be documented descriptively, and it should never be presented as evidence that the patient is consciously choosing when to move. Finkelstein and Popkirov, 2023; Mavroudis et al., 2025.
Positive signs in functional tremor and other movement symptoms
Distractibility and entrainment in functional tremor
In a suspected functional tremor, a clinician may observe the rhythm, distribution, and amplitude of the movement at rest, during posture, and during actions. They may then ask the person to perform a controlled tapping task with another limb. Entrainment describes a characteristic tendency for the tremor frequency to shift toward the externally requested tapping rhythm. Distractibility describes a reproducible reduction or alteration in the tremor under attention-demanding tasks.
These findings help support a positive functional tremor diagnosis when properly observed. They are interpreted together with the entire movement examination because tremor can vary in other conditions, and functional tremor can coexist with an established organic movement disorder. Electrophysiological tremor analysis may be useful in selected specialist cases. Neither variability nor distractibility in isolation should be treated as an infallible diagnostic test. Aybek and Perez, 2022; Mavroudis et al., 2025.
Functional gait symptoms
Some functional gait presentations exhibit inconsistencies between specific tasks or disproportionate differences between apparent balance difficulty and the person's actual ability to recover posture. The clinician evaluates walking, turning, transfers, tandem tasks if safe, and whether the pattern changes with supportive techniques or altered attentional demands. Some individuals can perform movements in one context that they cannot reliably access in another.
Walking patterns are diverse and influenced by pain, vestibular disease, sensory neuropathy, medication, fear of falling, and fatigue. A dramatic-looking gait is not sufficient evidence of FND. Any provocative examination task must respect fall risk and the patient's physical limits. Positive signs in gait disorders have a heterogeneous evidence base and require experienced interpretation. Mavroudis et al., 2025; Finkelstein and Popkirov, 2023.
Dystonia, jerks, and other abnormal movements
Functional dystonia and functional myoclonus require more specialized evaluation. Symptom variability, patterns of muscle activation, onset history, electrophysiological findings in selected cases, and the movement-disorder examination may inform the diagnosis. Fixed postures, sudden onset, and task-specific features may raise suspicion but are not alone sufficient to label a movement functional. The differential includes primary dystonia, other neurological movement disorders, medication-associated movements, and painful musculoskeletal conditions. Mavroudis et al., 2025.
How functional seizures are diagnosed
Functional seizures, also called psychogenic nonepileptic seizures (PNES) in much of the historical literature, are episodes that can resemble epileptic seizures but have a different underlying mechanism. Clinicians evaluate the person's typical events, eyewitness accounts, recordings, clinical history, and possible coexisting epilepsy. Their appearance may be highly distressing, and a person may experience impaired awareness or loss of control.
When feasible, video-EEG recording of the person's typical event, interpreted by qualified specialists and matched to the history, is the diagnostic reference standard. A routine EEG between events can be normal in people with epilepsy; therefore, a normal routine EEG is not proof of functional seizures. Even an event without an obvious epileptiform scalp EEG correlate requires expert interpretation because some epileptic seizures can have limited scalp EEG expression. A single video may be suggestive but is rarely an adequate substitute for comprehensive assessment when diagnostic uncertainty is important. AAN functional seizures guideline, 2026.
The 2026 American Academy of Neurology guideline recommends gathering detailed descriptions of seizure-like episodes, including witness and smartphone video information, considering video-EEG of all typical episode types when feasible, and assessing for co-occurring epilepsy and psychiatric conditions. Patients may have both functional and epileptic seizures, so the plan must distinguish their individual event patterns where possible. Antiseizure medications are appropriate for diagnosed epilepsy and other established indications; changes to prescribed drugs require the treating clinician's direction. AAN guideline executive summary.
Certain semiological characteristics may contribute to suspicion of functional or epileptic seizures, but no isolated feature such as crying, eye closure, emotional distress, or limb movement proves an event type in every patient. A newly occurring seizure-like event or an event markedly different from the person's established pattern deserves medical assessment. Finkelstein and Popkirov, 2023.
Sensory, visual, speech, and swallowing symptoms
Functional sensory symptoms can include altered sensation, numbness, or unusual patterns of sensory loss. The examiner assesses modality, distribution, consistency, and the wider neurological context. Features that do not fit a typical nerve or spinal cord distribution sometimes support a functional formulation, but unusual sensory maps and midline distinctions have limitations and can occur for several reasons. Sensory findings need greater contextual interpretation than the most established functional motor signs.
Speech symptoms may include changes in voice or fluency, and swallowing complaints may require specialist speech-language and medical evaluation. Visual symptoms call for an appropriate neurological or ophthalmological examination. When clinicians identify functional features, they still assess risks such as aspiration, dangerous visual impairment, or an accompanying structural disorder where indicated. The range of presentations should not be compressed into the assumption that a single bedside trick diagnoses all FND. Aybek and Perez, 2022; Mavroudis et al., 2025.
Cognitive complaints and the status of functional cognitive disorder
People with functional cognitive symptoms may report significant forgetfulness, concentration problems, difficulty following conversations, or other cognitive concerns. A specialist may identify internal inconsistencies between how a cognitive ability functions in different contexts. This involves careful clinical interpretation, longitudinal history, and, when appropriate, neuropsychological assessment.
Functional cognitive disorder (FCD) is an active area of clinical research. Proposed criteria emphasize cognitive complaints, evidence of internal inconsistency, functional impact, and consideration of other diagnoses. Those proposed criteria have not been universally established as an independently validated diagnostic category. A 2025 international Delphi study explicitly identified limited external validation and unresolved inter-rater reliability for proposed positive features. A separate 2025 checklist study provides developing evidence rather than a stand-alone home test. Cabreira et al., 2025 Delphi study; Cabreira et al., 2025 checklist development.
The differential includes sleep disorders, medication effects, mood disorders, attention difficulties, neurological illness, and neurodegenerative disease when clinically plausible. Performance that varies across contexts does not automatically exclude early dementia or another neurological disorder. Clinicians decide whether imaging, laboratory evaluation, formal cognitive assessment, or longitudinal follow-up is appropriate. Ball et al., 2020.
Which tests are used, and what do the results mean?
MRI and CT
Brain or spinal imaging is selected to investigate a relevant anatomical concern, especially with acute onset, focal findings, a progressive pattern, or another red flag. Imaging may identify stroke, inflammation, tumors, spinal pathology, or other conditions when those are clinically suspected. A normal scan does not by itself establish FND. A scan showing a neurological disorder does not automatically explain every concurrent symptom, either. The question is whether each important clinical finding is adequately accounted for. Aybek and Perez, 2022.
EEG and video-EEG
EEG evaluates electrical activity in the brain and is especially relevant when epileptic events are possible. Video-EEG adds synchronized observation of a typical episode to electrical monitoring. Recording a representative event often provides stronger evidence than an isolated resting study. The decision to use inpatient monitoring, ambulatory studies, or other approaches is guided by the event pattern and available specialist resources. AAN functional seizures guideline, 2026.
EMG, nerve conduction, and movement physiology
Electromyography and nerve-conduction studies assess selected neuromuscular or peripheral nerve conditions; they may also support specialist analysis of tremor or jerks when indicated. The clinical question determines what the test can answer. A normal peripheral nerve study does not constitute a general test for FND, and an abnormal study requires anatomical and clinical interpretation.
Blood tests and other investigations
Blood investigations may evaluate metabolic, endocrine, nutritional, inflammatory, or medication-related contributors when relevant. Vestibular, cardiological, autonomic, or ophthalmological assessment may be appropriate for particular symptom profiles. Conditions such as migraine, syncope, vestibular disorders, autonomic disorders, and chronic pain may coexist with functional symptoms, and should receive their own proper assessments rather than being automatically absorbed into an FND label.
Differential diagnosis: what clinicians must consider
Stroke and transient neurological events
Acute new one-sided weakness, facial droop, speech disturbance, visual loss, or other sudden neurological changes need emergency evaluation because stroke treatment is time-sensitive. FND can present as a stroke mimic, but apparent inconsistency or a history of FND should never delay the emergency pathway for an event that could be vascular. A clinician may ultimately diagnose a functional presentation after appropriate acute assessment. That diagnosis must be grounded in the event and examination in front of them. Finkelstein and Popkirov, 2023.
Epilepsy, syncope, and cardiac or autonomic events
Episodes of collapse or shaking may have epileptic, functional, cardiovascular, metabolic, sleep-related, or other causes. A clinical account, examination, and targeted testing can distinguish these possibilities. Multiple event types may coexist, making a written description of each established pattern valuable. The neurological and cardiological differential should reflect the actual clinical presentation. AAN functional seizures guideline, 2026.
Multiple sclerosis and other neurological disorders
Multiple sclerosis, movement disorders, migraine, neuropathy, spinal cord disease, myasthenia, and other conditions can occasionally overlap phenomenologically with FND. Diagnostic error can occur in both directions. A systematic review of FND and multiple sclerosis describes problems caused by overreliance on psychiatric history when diagnosing FND or imaging alone when diagnosing MS; it also discusses the possibility of both conditions occurring in one patient. Walzl et al., 2022.
Anxiety, panic, trauma-related symptoms, and dissociation
Panic can produce shaking, dizziness, altered sensation, breathlessness, and perceived loss of control. Trauma-related or dissociative symptoms can overlap with neurological presentations. A clinician determines whether an anxiety, trauma-related, dissociative, functional neurological, or medical diagnosis accounts for the specific episode; several can coexist. Emotional symptoms, by themselves, do not establish an FND diagnosis. A broader comparison of acute episodes appears in Panic Attack vs Seizure: Symptoms, Awareness, and Medical Assessment.
Intentional symptom production
FND clinical diagnosis relies on neurological evidence, not on attributing intent. Factitious disorder and malingering involve separate questions about intentionality and clinical or external context. A patient's presentation, a dramatic event, a changing symptom, disagreement about an explanation, or inconsistent test performance does not establish deliberate deception. Such high-stakes judgments require an appropriate professional assessment rather than speculation.
Can someone have FND and a neurological disease at the same time?
Yes. FND can coexist with epilepsy, multiple sclerosis, Parkinsonian or other movement disorders, migraine, and a variety of other medical conditions. A positive sign may support a functional component in one symptom while a different examination finding supports a distinct neurological process. A neurologist should document which symptom patterns are being attributed to which conditions and the remaining uncertainty.
This coexistence is one reason diagnostic reasoning is symptom-specific. A patient can have convincing functional leg weakness and another disease that requires ongoing monitoring. A new seizure type may require reevaluation even if an earlier type was documented as functional. The presence of FND does not remove access to appropriate future medical investigations. Aybek and Perez, 2022; Walzl et al., 2022.
When should symptoms be reassessed urgently?
Seek emergency care for sudden new stroke-like symptoms, a first or very different seizure-like episode, prolonged impaired awareness, severe injury during an episode, new severe headache with neurological changes, new spinal cord warning signs, or other acutely concerning changes. Chest pain with alarming associated symptoms, severe breathing problems, or loss of consciousness with possible cardiac cause also requires immediate medical attention.
Urgency depends on the actual symptoms and context, including pregnancy, age, medications, other diagnoses, and local emergency guidance. Previous FND documentation cannot substitute for assessment of a new dangerous presentation. For nonemergency but meaningful symptom progression, new deficits, new persistent cognitive changes, or a mismatch between the explanation and observed findings, arrange timely reassessment with an appropriate clinician.
What an FND diagnosis should explain to the patient
A high-quality explanation should state the name of the diagnosis, describe the specific positive findings that support it, explain the appropriate alternative conditions considered, clarify the purpose and limitations of any tests performed, and establish a follow-up plan. Demonstrating a reproducible sign can help when it is done with the person's consent and without turning the encounter into a performance test.
An explanation may discuss problems accessing automatic patterns of movement or regulating functional neurological networks, using language that reflects the evidence and the patient's symptoms. Neurobiological network and predictive-processing models remain subjects of research; they are useful conceptual approaches rather than an individually definitive causal biomarker. A clinician should not assert that trauma or stress produced a patient's FND merely because those experiences are present. Aybek and Perez, 2022; Mavroudis et al., 2025.
The diagnosis should connect to a care plan rather than end with a label. For motor symptoms, specialist physical or occupational therapy may focus on restoring automatic, functional movement and safely increasing participation. Speech-language therapy may be relevant to communication or swallowing presentations. For functional seizures, neurologists and mental health professionals coordinate treatment, and psychological interventions may improve event outcomes for some patients. Management varies by subtype, comorbidities, access to services, and individual goals. AAN functional seizures guideline, 2026; Physiotherapy consensus, 2015.
The prognosis varies. Some people improve markedly with clear diagnosis and targeted rehabilitation; others have persistent symptoms and disability. Diagnosis can guide treatment without implying an automatic cure. The importance of early appropriate explanation and follow-up is supported by clinical reviews, while long-term outcome evidence differs by subtype and intervention. Aybek and Perez, 2022.
Diagnosis in children and adolescents
In young people, FND-related or other somatic presentations require developmentally appropriate medical assessment, attention to changes in school attendance, physical activity, sleep, family routines, friendships, and emotional well-being, and communication understandable to the child. Parents and caregivers may provide valuable descriptions but should not be recruited into challenging a child's credibility. School participation and rehabilitation goals should reflect the child's health and safety.
The Canadian Paediatric Society recommends an integrated approach that validates symptoms, evaluates potential medical conditions, coordinates family-centered care, and addresses functional recovery and school needs. The evidence and clinical setting for adult neurological signs should not be assumed to apply unchanged across every pediatric age. Canadian Paediatric Society, 2024.
Why a second opinion or follow-up can be appropriate
A second neurological opinion can be useful when the examination findings were not explained, the diagnosis was based mainly on unrevealing tests, significant red flags were not addressed, the symptoms evolve in a concerning manner, or the patient needs specialized seizure or movement evaluation. It can also help when another neurological diagnosis is present and the contribution of each condition remains unclear.
Reassessment is a standard feature of careful longitudinal clinical care. The goal is to obtain a clinically specific explanation, reconcile the available findings, identify necessary investigations, and arrange effective treatment. Repeated indiscriminate testing can also be burdensome; the decision to investigate should follow new evidence, examination findings, and a clear medical question. Finkelstein and Popkirov, 2023.
Practical questions to ask at an FND diagnostic appointment
Patients may ask which findings positively support their diagnosis, which other diagnoses were considered, what each test has or has not established, whether any symptom warrants separate evaluation, and which changes should prompt urgent reassessment. They can ask how their condition will be documented, who will coordinate care, which therapies match their symptom subtype, what progress to monitor, and how to access relevant rehabilitation or psychological services.
A written summary is particularly useful when the person has multiple symptoms, fluctuating function, cognitive complaints, or several clinical teams. For events that resemble seizures, asking whether epilepsy was adequately assessed and whether different episode types were captured is especially important. The patient should be able to understand the positive evidence for FND as well as the plan for continuing medical care.
Frequently asked questions
Is FND diagnosed only after every other condition is ruled out?
No. Clinicians can diagnose many FND presentations using positive signs characteristic of a functional pattern. They also investigate alternative diagnoses and comorbidities when the symptoms and examination indicate a need. Positive diagnosis and appropriate exclusion of competing causes are complementary parts of good practice.
Is a normal MRI enough to diagnose FND?
No. A normal MRI may be relevant to a particular differential diagnosis, but MRI does not identify the defining positive bedside pattern of every functional symptom. The diagnosis depends on the clinical history, examination, and appropriately selected investigations.
What is Hoover's sign, and does a positive sign prove FND?
Hoover's sign assesses a characteristic change in leg extension force across voluntary and automatic tasks. A positive finding can support functional limb weakness when the maneuver is technically valid, but its diagnostic accuracy estimates are based on limited studies. It must be interpreted with other clinical findings. Practical guide to functional motor weakness, 2025.
Can functional tremor be distinguished from Parkinson's disease?
A movement-disorder specialist can examine tremor characteristics and look for positive functional features, alongside signs of Parkinsonian disease and other causes. Functional and neurodegenerative features can coexist, so assessment is individualized.
Can a person have both functional seizures and epilepsy?
Yes. Both event types can occur in one person. The AAN recommends evaluating for co-occurring epilepsy, obtaining descriptions or recordings of typical episodes, and using video-EEG when feasible. Medication decisions should account for any confirmed epileptic seizures. AAN functional seizures guideline, 2026.
Does an FND diagnosis require trauma or a mental health diagnosis?
No. A history of trauma, an immediate stressful event, or a psychiatric diagnosis is not required for the DSM-5-TR diagnosis. Psychological assessment may help identify comorbid needs or support a treatment plan, while the FND diagnosis itself rests on appropriate clinical evidence.
Are FND symptoms intentional?
A functional neurological presentation does not establish intentional production of symptoms. Differences between automatic and voluntary movement, for example, are clinical observations about function. Deliberate deception cannot be inferred from a fluctuating symptom or positive sign.
Can FND and multiple sclerosis coexist?
Yes. They can coexist and can sometimes be confused with each other. Careful clinical localization, neurological signs, imaging where indicated, and follow-up matter. Walzl et al., 2022.
Is there a blood test or brain scan that confirms FND?
There is no universally accepted single laboratory test or routine structural scan that confirms all FND presentations. Clinicians use symptom-specific positive clinical findings and targeted investigations. Research techniques that reveal group-level differences in brain activity should not be presented as established individual diagnostic tests.
What if symptoms change after the diagnosis?
New or substantially changed symptoms require reconsideration according to their clinical urgency. Emergency warning signs need immediate evaluation, and important progressive or unexpected findings warrant appropriate medical follow-up. An earlier FND diagnosis does not explain every future neurological event.
Evidence strengths and remaining uncertainties
The strongest practical consensus concerns positive neurological assessment, subtype-specific examination, appropriate differential diagnosis, and communicating a defensible clinical formulation. Evidence for the accuracy of many bedside signs remains uneven, and several frequently cited numbers come from small or selected studies. The 2025 review that proposed a cross-subtype clinical decision tool explicitly identified a need for future clinical validation; its proposed tool should not be treated as an independently established diagnostic standard. Mavroudis et al., 2025.
For functional seizures, a formal AAN guideline now provides recommendations grounded in a systematic review of studies through February 2025, but diagnostic and treatment conclusions still require individualized application. For functional cognitive disorder, proposed criteria and pilot checklists are developing research, and external validation remains an important gap. Evidence about mechanisms such as altered predictions, attention, agency, and brain-network interactions continues to evolve. None of these frameworks supplies an individual causal test that replaces careful clinical assessment. AAN guideline, 2026; Cabreira et al., 2025.
Related Articles
For the history of earlier diagnostic terminology, see Conversion Neurosis: Historical Meaning and Functional Neurological Symptom Disorder. For an adjacent differential question involving episodes of fear and altered awareness, see Panic Attack vs Seizure: Symptoms, Awareness, and Medical Assessment. Future EN-14 articles will cover the condition-wide FND overview, treatment and rehabilitation, and subtype-specific neurological signs in greater detail.
References
American Academy of Neurology. (2026). Management of functional seizures practice guideline executive summary. Neurology. https://doi.org/10.1212/WNL.0000000000214466.
American Psychiatric Association. (2022). Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision: Somatic Symptom and Related Disorders. https://doi.org/10.1176/appi.books.9780890425787.x09_Somatic_Symptom_and_Related_Disorders.
American Psychiatric Association. (2022). DSM-5-TR update: Functional neurological symptom disorder. https://www.psychiatry.org/getmedia/c57b724e-7fc7-4082-bbbf-28b458709b51/APA-DSM5TR-FunctionalNeurologicalSymptomDisorder.pdf.
Aybek, S., & Perez, D. L. (2022). Diagnosis and management of functional neurological disorder. BMJ, 376, o64. https://www.bmj.com/content/376/bmj.o64.
Ball, H. A., McWhirter, L., Ballard, C., Bhome, R., Blackburn, D. J., Edwards, M. J., Fleming, S. M., Fox, N. C., Howard, R., Huntley, J., et al. (2020). Functional cognitive disorder: Dementia's blind spot. Brain, 143, 2895–2903. https://academic.oup.com/brain/article/143/10/2895/5892366.
Cabreira, V., et al. (2025). Development of a diagnostic checklist to identify functional cognitive disorder versus other neurocognitive disorders. BMJ Neurology Open, 7, e000918. https://neurologyopen.bmj.com/content/7/1/e000918.
Cabreira, V., et al. (2025). Perspectives on the diagnosis and management of functional cognitive disorder: An international Delphi study. European Journal of Neurology, 32, e16318. https://doi.org/10.1111/ene.16318.
Canadian Paediatric Society. (2024). Somatic symptom and related disorders: Guidance on assessment and management for paediatric health care providers. https://cps.ca/en/documents/position/somatic-symptom-and-related-disorders.
Dolbow, J., El-Azzouni, S., Zhang, Y., & Geiger, C. (2025). A practical guide to assessing functional motor weakness: A review of validated techniques. Journal of Neurology, 272, 427. https://doi.org/10.1007/s00415-025-13139-4.
Finkelstein, S. A., & Popkirov, S. (2023). Functional neurological disorder: Diagnostic pitfalls and differential diagnostic considerations. Neurologic Clinics, 41, 665–679. https://doi.org/10.1016/j.ncl.2023.04.001.
First, M. B., et al. (2021). An organization- and category-level comparison of diagnostic requirements for mental disorders in ICD-11 and DSM-5. World Psychiatry. https://doi.org/10.1002/wps.20825.
Mavroudis, I., et al. (2025). Positive clinical signs in functional neurological disorders: A narrative review and development of a clinical decision tool. Brain Sciences, 15, 997. https://doi.org/10.3390/brainsci15090997.
Physiotherapy for functional motor disorders: A consensus recommendation. (2015). Journal of Neurology, Neurosurgery & Psychiatry. https://pmc.ncbi.nlm.nih.gov/articles/PMC4602268/.
Walzl, D., et al. (2022). Functional neurological disorder and multiple sclerosis: A systematic review of misdiagnosis and clinical overlap. Journal of Neurology. https://doi.org/10.1007/s00415-021-10436-6.
World Health Organization. (2024). Clinical Descriptions and Diagnostic Requirements for ICD-11 Mental, Behavioural and Neurodevelopmental Disorders. https://www.who.int/publications/i/item/9789240077263.